Lars Dähne was born in 1959 in Berlin, Germany. He
studied chemistry at Humboldt University, Berlin. In 1991, he received a
Ph.D. in organic chemistry for his research on “Laser photochemistry of
Phenylazides and nitrenes” After his postdoc, he stayed in Japan, and after one year of dye
synthesis at the TU Braunschweig (Prof. W. Grahn), he moved to the Free
University, Berlin, and worked on intermolecular dye interactions. For this work,
he obtained a habilitation in physical chemistry and the Otto-Röhm Memorial
prize in 1998. In 1999, he moved to the Max-Planck Institute of Colloids and
Interfaces and started research on polyelectrolyte Layer-by-Layer (LbL) films
in the group of Prof. H. Möhwald. In 2001, L. Dähne co-founded the company Capsulution Nanoscience AG, where he worked as the head of
the life science department. In 2008, he founded the research company Surflay
Nanotec GmbH, where he is the CEO. L. Dähne has published more than 100
refereed papers in international journals and holds several patents. His main research
interests are LbL technology, synthesis and functionalization of nano- and
microparticles, bioanalytics, and drug delivery of biological macromolecules.
Lars Dähne was born in 1959 in Berlin, Germany. He
studied chemistry at Humboldt University, Berlin. In 1991, he received a
Ph.D. in organic chemistry for his research on “Laser photochemistry of
Phenylazides and nitrenes” After his postdoc, he stayed in Japan, and after one year of dye
synthesis at the TU Braunschweig (Prof. W. Grahn), he moved to the Free
University, Berlin, and worked on intermolecular dye interactions. For this work,
he obtained a habilitation in physical chemistry and the Otto-Röhm Memorial
prize in 1998. In 1999, he moved to the Max-Planck Institute of Colloids and
Interfaces and started research on polyelectrolyte Layer-by-Layer (LbL) films
in the group of Prof. H. Möhwald. In 2001, L. Dähne co-founded the company Capsulution Nanoscience AG, where he worked as the head of
the life science department. In 2008, he founded the research company Surflay
Nanotec GmbH, where he is the CEO. L. Dähne has published more than 100
refereed papers in international journals and holds several patents. His main research
interests are LbL technology, synthesis and functionalization of nano- and
microparticles, bioanalytics, and drug delivery of biological macromolecules.